Status:
COMPLETED
The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy
Lead Sponsor:
Carol Davila University of Medicine and Pharmacy
Conditions:
Upper Gastrointestinal Endoscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators aim to establish wether the administration of pancreatic enzyme replacement therapy (PERT) improves visibility of the mucosa during upper gastrointestinal endoscopy.
Detailed Description
Upper gastrointestinal endoscopy is done "a jeun", without any solid foods at least 8 hours before procedure and no water at least 2 hours before procedure. Often, the visibility of the mucosa is sub...
Eligibility Criteria
Inclusion
- patient with upper gastrointestinal endoscopy indication, with topical pharyngeal anesthesia
- age above 18 years old
- informed consent
Exclusion
- allergy to KREON and/or sodium bicarbonate
- upper gastrointestinal bleeding clinically manifest (hematemesis, melena, hematochesia)
- ingested foreign body
- personal history of esophagectomy, partial or total gastectomy
- absence of informed consent
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06218537
Start Date
August 1 2024
End Date
August 31 2024
Last Update
November 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Agrippa Ionescu" Hospital
Bucharest, Romania